Unlike SKOV3 and A498, levels of c-MET and EGFR were not lowered by NRF2 knockdown in colorectal carcinoma HT29 and breast carcinoma MDA-MB231 cells (Figure 5A and 5B). This evidence concerns the gene EGFR and colorectal carcinoma.